AI MARKET SCANNING

Neurocrine Biosciences, Inc.

🏛️ NASDAQ 📁 Healthcare 🏭 Drug Manufacturers – Specialty & Generic
AVG HISTORICAL GAP -0.52%
MAX GAP RECORD -16.28%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $NBIX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Jul 30, 2026 Earnings Release 2026-07-30 (AFTER CLOSE)
-0.63%
May 05, 2026 Earnings Release 2026-05-05 (AFTER CLOSE)
+10.31%
Feb 11, 2026 Earnings Release 2026-02-11 (AFTER CLOSE)
-3.71%
Oct 28, 2025 Earnings Release 2025-10-28 (AFTER CLOSE)
-5.01%
Jul 30, 2025 Earnings Release 2025-07-30 (AFTER CLOSE)
+0.25%
May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE)
+0.27%
Feb 06, 2025 Earnings Release 2025-02-06 (AFTER CLOSE)
-16.28%
Oct 30, 2024 Earnings Release 2024-10-30 (BEFORE OPEN)
+8.84%

VOLATILITY & GAP BIAS

AVG GAP MOVE 4.5%
Bullish Gaps (4)
Bearish Gaps (5)
Neutral / Flat (6)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $NBIX

EXECUTIONS2 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-30 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 951m +0.00%
••••-••-•• 🔒 LOCKED ••• x• $•••.•• → $•••.•• ••m +••.••%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗